Balyasny Asset Management »

Kalvista Pharmaceuticals shares owned by Balyasny Asset Management

Quarter-by-quarter ownership of Kalvista Pharmaceuticals (KALV) shares owned by Balyasny Asset Management from 13F filings

Historical chart of Balyasny Asset Management investment in Kalvista Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Kalvista Pharmaceuticals held by Balyasny Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kalvista Pharmaceuticals by Balyasny Asset Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $146k 12k 12.25
2023-09-30 $103k 11k 9.63

More positions owned by Balyasny Asset Management

Ishares Tr Russell 2000 Etf (IWM)
Microsoft Corporation Call Option (MSFT)
Apple (AAPL)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Select Sector Spdr Tr Financial (XLF)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Hess Put Option (HES)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Amazon (AMZN)
JPMorgan Chase & Co. Call Option (JPM)
Ishares Tr Core S&p Mcp Etf (IJH)
Union Pacific Corporation Call Option (UNP)
Select Sector Spdr Tr Technology (XLK)
Boeing Company (BA)
Deere & Company (DE)

View all positions for Balyasny Asset Management

Top funds holding Kalvista Pharmaceuticals

VR Adviser
Frazier Life Sciences Management
Tang Capital Management
Vanguard Group
Boxer Capital
Caption Management
Citadel Advisors
Dimensional Fund Advisors
DAFNA Capital Management
Goldman Sachs Group
Rosalind Advisors
Citigroup
Two Sigma Advisers
Two Sigma Investments
Opaleye Management

View all funds holding Kalvista Pharmaceuticals